Clinical Trial Update: Optimal Antithrombotic Therapy in Ischemic Stroke Patients with Non-Valvular Atrial Fibrillation and Atherothrombosis [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial evaluating optimal antithrombotic therapy in ischemic stroke patients with non-valvular atrial fibrillation and atherothrombosis has be…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atherothrombosis
• Atrial Fibrillation
• Stroke

Snippet

Sponsor: National Hospital Organization Osaka National Hospital | Conditions: Ischemic Stroke, Atrial Fibrillation | Phase 4 | Status: TERMINATED